AllianceBernstein
FENC icon

AllianceBernstein’s Fennec Pharmaceuticals FENC Stock Holding History

AllianceBernstein’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Buy
16,570
+6,260
+61% +$51.1K ﹤0.01% 3255
2026
Q1 		$79.4K Hold
10,310
– – ﹤0.01% 3175
2025
Q4 		$79.4K Hold
10,310
– – ﹤0.01% 3187
2025
Q3 		$96.5K Buy
+10,310
New +$89.3K ﹤0.01% 3183

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AllianceBernstein's FENC Position: Q2 2026 in Review

AllianceBernstein increased its Fennec Pharmaceuticals (FENC) stake by 61% in Q2 2026, buying an estimated $51.1K and bringing the position to 16,570 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #3255.

AllianceBernstein first reported a position in FENC in Q3 2025 and has held it in 4 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • AllianceBernstein held 16,570 shares of Fennec Pharmaceuticals worth $102K as of Q2 2026.
  • AllianceBernstein bought 6,260 Fennec Pharmaceuticals shares in Q2 2026, an estimated $51.1K.
  • Fennec Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3255 holding.
  • AllianceBernstein first reported a position in Fennec Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.